News & Trends - MedTech & Diagnostics
Medicare-funded lifeline fuels community action in cardiovascular disease
With the Medicare-funded Heart Health Check extension set to begin on 1 July 2025, advocates are recognising the significance of […]
MoreNews & Trends - MedTech & Diagnostics
Medtech priorities for Labor’s second term: Time to deliver
Ian Burgess, CEO of Medical Technology Association of Australia (MTAA), and Liz Carnabuci, VP & MD of Medtronic ANZ and Chair […]
MoreNews & Trends - MedTech & Diagnostics
Scalpel meets the bottom line: Healthscope collapse spurs sector-wide call for reform
The collapse of private hospital giant Healthscope has sent shockwaves through the healthcare community, reigniting urgent concerns about the future […]
MoreNews & Trends - MedTech & Diagnostics
Healthscope’s collapse sparks urgent calls for oversight amid fears for patient care and workforce
As Healthscope, Australia’s second-largest private hospital group, enters receivership, healthcare leaders are sounding the alarm on the potential fallout for […]
MoreNews & Trends - MedTech & Diagnostics
Healthscope $1.4B debt triggers receivership, Health Minister rules out taxpayer bailout
Healthscope, Australia’s second-largest private hospital group, has collapsed into receivership. Two major banks, Commonwealth Bank (CBA) and Westpac, have stepped […]
MoreNews & Trends - MedTech & Diagnostics
Health minister vows hospital funding deal by Christmas
With Labor back in power, stakeholders are expecting renewed momentum on the five-year National Health Reform Agreement (NHRA). Negotiations on […]
MoreNews & Trends - MedTech & Diagnostics
‘Pain Factory’ fallout: Dr Faux confronts medical colleges over Medicare billing misinformation
More than a year after the ABC’s explosive Four Corners investigation Pain Factory aired in April 2024, deep divisions in […]
MoreNews & Trends - MedTech & Diagnostics
Health insurers accused of hijacking patient care
The healthcare sector is under intense scrutiny, as the Australian Medical Association (AMA) and Catholic Health Australia (CHA) warn that […]
MoreNews & Trends - MedTech & Diagnostics
Budget rewire: Victoria’s $11 billion health injection
Victoria is recalibrating its healthcare system with an $11.1 billion injection in the state budget – an investment designed not […]
MoreNews & Trends - MedTech & Diagnostics
Inquiry report exposes brutal truths about NSW public health system
The long-awaited report from the Special Commission of Inquiry into Healthcare Funding has delivered a searing assessment of the NSW […]
MoreRecent Posts in Pharma, MedTech & Biotech
NRF backs local ophthalmic biotech
May 30, 2025
in News & Trends - Biotechnology
Who’s accountable for Australia’s private hospital meltdown?
May 30, 2025
in News & Trends - MedTech & Diagnostics
Medicare-funded lifeline fuels community action in cardiovascular disease
May 30, 2025
in News & Trends - MedTech & Diagnostics
Growth hormone therapy gains TGA nod
May 30, 2025
in News & Trends - Pharmaceuticals
Medtech priorities for Labor’s second term: Time to deliver
May 28, 2025
in News & Trends - MedTech & Diagnostics
Shifting the curve: Long-term data redefines survival in metastatic prostate cancer
May 28, 2025
in News & Trends - Pharmaceuticals
Australia at a crossroads in obesity management: Experts call for strategic use of GLP-1 receptor agonists
May 28, 2025
in News & Trends - Pharmaceuticals
Scalpel meets the bottom line: Healthscope collapse spurs sector-wide call for reform
May 28, 2025
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - Biotechnology
NRF backs local ophthalmic biotech
A Melbourne-based biotechnology company has landed a game-changing investment to push forward its novel glaucoma implant to address the long-standing […]
MoreNews & Trends - MedTech & Diagnostics
Who’s accountable for Australia’s private hospital meltdown?
Private hospitals across Australia are facing an unprecedented viability crisis, one that healthcare leaders say has been worsened by profit-hungry […]
MoreNews & Trends - MedTech & Diagnostics
Medicare-funded lifeline fuels community action in cardiovascular disease
With the Medicare-funded Heart Health Check extension set to begin on 1 July 2025, advocates are recognising the significance of […]
MoreNews & Trends - Pharmaceuticals
Growth hormone therapy gains TGA nod
The Therapeutic Goods Administration (TGA) has approved a new growth hormone deficiency (GHD) treatment for children and adolescents, expanding options […]
More